Elsevier

Experimental Cell Research

Volume 226, Issue 2, 1 August 1996, Pages 387-397
Experimental Cell Research

Regular Article
Monoclonal Antibody to Single-Stranded DNA Is a Specific and Sensitive Cellular Marker of Apoptosis

https://doi.org/10.1006/excr.1996.0240Get rights and content

Abstract

The most widely used histochemical marker of apoptosis (in situend labeling, TUNEL) detects both apoptotic and necrotic cells and evaluates only late stages of apoptosis. Hence, a specific and sensitive cellular marker of apoptosis is needed to determine the role of apoptotic death in biology and pathology. The present study describes a novel immunohistochemical procedure for the staining of apoptotic cells using a monoclonal antibody (MAb) to single-stranded DNA. This MAb stained all cells with the morphology typical of apoptosis in etoposide-treated HL-60, MOLT-4, and R9 cell cultures, in which apoptosis was accompanied by high, moderate, and low levels of internucleosomal DNA fragmentation, respectively. TUNEL stained all apoptotic cells in HL-60 cultures, nearly 60% of apoptotic cells in MOLT-4 cultures, and only 14% of apoptotic cells in R9 cultures. Apoptotic R9 cells, which progressed into secondary necrosis, retained MAb staining and became TUNEL-positive. Necrotic cells in MOLT-4 cultures treated with sodium azide were stained by TUNEL, but were negative for MAb staining. All floating cells at a late stage of apoptosis in MDA-MB-468 cultures treated with cisplatin were stained by both MAb and TUNEL. However, among adherent cells in the early stages of apoptosis, MAb stained nearly 20 times more cells than TUNEL. In histological sections of human tumor xenografts, MAb detected clusters of apoptotic cells in viable tumor tissue, but did not stain cells in areas of central ischemic necrosis. In contrast, TUNEL stained nuclei in necrotic areas. Thus, MAb to single-stranded DNA is a specific and sensitive cellular marker of apoptosis, which differentiates between apoptosis and necrosis and detects cells in the early stages of apoptosis.

References (0)

Cited by (234)

  • Pirfenidone alleviates lung ischemia-reperfusion injury in a rat model

    2019, Journal of Thoracic and Cardiovascular Surgery
    Citation Excerpt :

    This study showed that pirfenidone significantly decreased both of these on lung IRI and reduced apoptotic cells according to the immunohistochemical staining of ssDNA. Staining with anti-ssDNA antibody has been shown to be a specific and sensitive procedure for the detection of apoptotic cells relative to terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling.24 In experiment 2, our results demonstrated that administration of pirfenidone orally by gavage in a rat IRI model increased concentrations of pirfenidone in blood and lung tissue within the experimental period.25-27

  • Food Yellow4 reprotoxicity in relation to localization of DMC1 and apoptosis in rat testes: Roles of royal jelly and cod liver oil

    2019, Ecotoxicology and Environmental Safety
    Citation Excerpt :

    The ssDNA antibody is a suitable marker for the early stages of apoptotic cell death associated with DNA damage. Therefore, its immunopositivity is detected in the nuclei of the damaged cells (Frankfurt et al., 1996). A dynamic balance between cell proliferation and apoptotic cell death has been observed throughout spermatogenesis (Shaha et al., 2010).

  • Single-cell omics in autoimmune disorders

    2019, Single-Cell Omics: Volume 2: Application in Biomedicine and Agriculture
View all citing articles on Scopus
1

To whom correspondence and reprint requests should be addressed at Oncology Laboratory, Cedars Medical Center, 1400 N.W. 10th Avenue, Miami, FL 33136. Fax: (305) 866-2736.

View full text